As we will review in the following sections, BMP10 seems to have different effects on tumor angiogenesis than BMP9 and BMP10 may explain the discrepancies observed between ALK1 targeting and direct BMP9 inhibition. The gene discussed is ACVRL1; the disease is neoplasm.